CBMM Vision and Mission Statement
The CBMM Purpose
The CBM2 vision is to design, manufacture, and deliver new tools to the biomedical community that utilize liquid biopsies for disease detection and management — Precision Medicine. Our mission is to make meaningful impact on people's well-being through the delivery of innovative and fully automated mixed-scale systems programmed for different disease states.
CBM2 is a multi-institutional Center (The University of Kansas, The University of Kansas Medical Center, Louisiana State University, Wake Forest Medical School, and The University of North Carolina-Chapel Hill), and is supported by the Biotechnology Resource Center mechanism from the National Institutes of Health (National Institute of Biomedical Imaging and Bioengineering; NIBIB).
